{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:04Z","timestamp":1786982824294,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mianyang Science and Technology Bureau","award":["2023ZYDF081"],"award-info":[{"award-number":["2023ZYDF081"]}]},{"name":"Mianyang Science and Technology Bureau","award":["2022ZYDF087"],"award-info":[{"award-number":["2022ZYDF087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteopenia (ON) and osteoporosis (OP) are highly prevalent among postmenopausal women and poses a challenge for early diagnosis. Therefore, identifying reliable biomarkers for early prediction using metabolomics is critically important.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Initially, non-targeted metabolomics was employed to identify differential metabolites in plasma samples from cohort 1, which included healthy controls (HC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923), osteonecrosis (ON,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200936), and osteoporosis (OP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937). Subsequently, we performed targeted metabolomic validation of 37 amino acids and their derivatives in plasma samples from cohort 2, consisting of healthy controls (HC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910), osteonecrosis (ON,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910), and osteoporosis (OP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The non-targeted metabolomic analysis revealed an increase in differential metabolites with the progression of the disease, showing abnormalities in lipid and organic acid metabolism in ON and OP patients. Several substances were found to correlate positively or negatively with bone mineral density (BMD), for example, N-undecanoylglycine, sphingomyelins, and phosphatidylinositols exhibited positive correlations with BMD, while acetic acid, phenylalanine, taurine, inosine, and pyruvic acid showed negative correlations with BMD. Subsequently, targeted validation of 37 amino acids and their metabolites revealed six amino acids related to ON and OP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Significant metabolomic features were identified between HC and patients with ON\/OP, with multiple metabolites correlating positively or negatively with BMD. Integrating both targeted and non-targeted metabolomic results suggests that lipid, organic acid, and amino acid metabolism may represent important metabolomic characteristics of patients with OP, offering new insights into the development of metabolomic applications in OP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-024-02923-3","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:46:30Z","timestamp":1737413190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls"],"prefix":"10.1007","volume":"37","author":[{"given":"Bing","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"3","key":"2923_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ (2016) Clinical practice. Postmenopausal osteoporosis. N Engl J Med 374(3):254\u2013262","journal-title":"N Engl J Med"},{"issue":"10169","key":"2923_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporos Lancet 393(10169):364\u2013376","journal-title":"Osteoporos Lancet"},{"issue":"2 Suppl 1","key":"2923_CR3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38(2 Suppl 1):S4\u20139","journal-title":"Bone"},{"issue":"5","key":"2923_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00198-018-4414-z","volume":"29","author":"VA Levin","year":"2018","unstructured":"Levin VA, Jiang X, Kagan R (2018) Estrogen therapy for osteoporosis in the modern era. Osteoporos Int 29(5):1049\u20131055","journal-title":"Osteoporos Int"},{"key":"2923_CR5","unstructured":"National Health Commisslon of the People\u2019s Republic of China Epidemiological Survey of Osteoporosis in Chinese Residents. [Accessed 14 Dec 2023]; Available from: http:\/\/www.nhc.gov.cn\/"},{"key":"2923_CR6","doi-asserted-by":"crossref","unstructured":"Lee DH, Joo MC (2022) Change in bone Mineral Density in Stroke patients with osteoporosis or Osteopenia. Int J Environ Res Public Health, 19(15)","DOI":"10.3390\/ijerph19158954"},{"key":"2923_CR7","first-page":"65","volume":"7","author":"T Willson","year":"2015","unstructured":"Willson T et al (2015) The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol 7:65\u201376","journal-title":"Clin Epidemiol"},{"issue":"3","key":"2923_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","volume":"79","author":"C Ginsberg","year":"2022","unstructured":"Ginsberg C, Ix JH (2022) Diagnosis and management of osteoporosis in advanced kidney disease: a review. Am J Kidney Dis 79(3):427\u2013436","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2923_CR9","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.3892\/mmr.2017.7620","volume":"16","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) Screening and validation of serum protein biomarkers for early postmenopausal osteoporosis diagnosis. Mol Med Rep 16(6):8427\u20138433","journal-title":"Mol Med Rep"},{"key":"2923_CR10","doi-asserted-by":"crossref","unstructured":"Nawrat-Szo\u0142tysik A et al (2020) Osteoporosis in Polish older women: risk factors and osteoporotic fractures: a cross-sectional study. Int J Environ Res Public Health, 17(10)","DOI":"10.3390\/ijerph17103725"},{"key":"2923_CR11","doi-asserted-by":"crossref","unstructured":"Kovvuru K et al (2020) Risk factors and management of osteoporosis post-transplant. Med (Kaunas), 56(6)","DOI":"10.3390\/medicina56060302"},{"key":"2923_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11657-013-0145-0","volume":"8","author":"WD Leslie","year":"2013","unstructured":"Leslie WD et al (2013) Direct comparison of eight national FRAX\u00ae tools for fracture prediction and treatment qualification in Canadian women. Arch Osteoporos 8:145","journal-title":"Arch Osteoporos"},{"issue":"3","key":"2923_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11914-023-00785-8","volume":"21","author":"KT Lau","year":"2023","unstructured":"Lau KT et al (2023) Metabolomics of osteoporosis in humans: a systematic review. Curr Osteoporos Rep 21(3):278\u2013288","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"2923_CR14","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","volume":"28","author":"T Buergel","year":"2022","unstructured":"Buergel T et al (2022) Metabolomic profiles predict individual multidisease outcomes. Nat Med 28(11):2309\u20132320","journal-title":"Nat Med"},{"key":"2923_CR15","doi-asserted-by":"crossref","unstructured":"Aleidi SM et al (2021) A distinctive human metabolomics Alteration Associated with Osteopenic and osteoporotic patients. Metabolites, 11(9)","DOI":"10.3390\/metabo11090628"},{"issue":"5","key":"2923_CR16","doi-asserted-by":"publisher","first-page":"e0217348","DOI":"10.1371\/journal.pone.0217348","volume":"14","author":"TA Pontes","year":"2019","unstructured":"Pontes TA et al (2019) Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics. PLoS ONE 14(5):e0217348","journal-title":"PLoS ONE"},{"key":"2923_CR17","doi-asserted-by":"crossref","unstructured":"Lv Z, Shi W, Zhang Q (2022) Role of essential amino acids in Age-Induced Bone loss. Int J Mol Sci, 23(19).","DOI":"10.3390\/ijms231911281"},{"issue":"10","key":"2923_CR18","doi-asserted-by":"publisher","first-page":"e3852","DOI":"10.1210\/clinem\/dgab492","volume":"106","author":"CW Ling","year":"2021","unstructured":"Ling CW et al (2021) The Association of Gut Microbiota with osteoporosis is mediated by amino acid metabolism: Multiomics in a large cohort. J Clin Endocrinol Metab 106(10):e3852\u2013e3864","journal-title":"J Clin Endocrinol Metab"},{"key":"2923_CR19","unstructured":"IOF WHAT IS OSTEOPOROSIS? [Accessed 01 Oct 2023]; Available from: https:\/\/www.osteoporosis.foundation\/patients\/about-osteoporosis"},{"key":"2923_CR20","unstructured":"Johns Hopkins Arthritis Center Osteoporosis Information. [Accessed 02 Jan 2024]; Available from: https:\/\/www.hopkinsarthritis.org\/arthritis-info\/osteoporosis-info\/"},{"key":"2923_CR21","doi-asserted-by":"crossref","unstructured":"Cabrera D et al (2018) Association of Plasma Lipids and Polar metabolites with Low Bone Mineral density in singaporean-chinese menopausal women: a pilot study. Int J Environ Res Public Health, 15(5)","DOI":"10.3390\/ijerph15051045"},{"issue":"5","key":"2923_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","volume":"1841","author":"M Taniguchi","year":"2014","unstructured":"Taniguchi M, Okazaki T (2014) The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. Biochim Biophys Acta 1841(5):692\u2013703","journal-title":"Biochim Biophys Acta"},{"key":"2923_CR23","doi-asserted-by":"publisher","first-page":"752540","DOI":"10.3389\/fcell.2021.752540","volume":"9","author":"T Qi","year":"2021","unstructured":"Qi T, Li L, Weidong T (2021) The role of Sphingolipid Metabolism in Bone Remodeling. Front Cell Dev Biol 9:752540","journal-title":"Front Cell Dev Biol"},{"key":"2923_CR24","doi-asserted-by":"crossref","unstructured":"Pekkinen M et al (2019) Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. JCI Insight, 4(7)","DOI":"10.1172\/jci.insight.126180"},{"key":"2923_CR25","doi-asserted-by":"publisher","first-page":"110893","DOI":"10.1016\/j.cbi.2024.110893","volume":"391","author":"LK Huang","year":"2024","unstructured":"Huang LK et al (2024) Echinacoside alleviates glucocorticoid induce osteonecrosis of femoral head in rats through PI3K\/AKT\/FOXO1 pathway. Chem Biol Interact 391:110893","journal-title":"Chem Biol Interact"},{"issue":"7","key":"2923_CR26","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00198-019-04892-0","volume":"30","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019) Discovery of potential biomarkers for osteoporosis using LC-MS\/MS metabolomic methods. Osteoporos Int 30(7):1491\u20131499","journal-title":"Osteoporos Int"},{"key":"2923_CR27","doi-asserted-by":"publisher","first-page":"103111","DOI":"10.1016\/j.ebiom.2020.103111","volume":"62","author":"Z Mei","year":"2020","unstructured":"Mei Z et al (2020) Association between the metabolome and bone mineral density in a Chinese population. EBioMedicine 62:103111","journal-title":"EBioMedicine"},{"issue":"11","key":"2923_CR28","first-page":"1960","volume":"48","author":"M Park","year":"2019","unstructured":"Park M, Choi HK, An JH (2019) Taurine activates BMP-2\/Wnt3a-Mediated osteoblast differentiation and mineralization via akt and MAPK signaling. Iran J Public Health 48(11):1960\u20131970","journal-title":"Iran J Public Health"},{"issue":"1\u20132","key":"2923_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2009.06.002","volume":"285","author":"D Keizman","year":"2009","unstructured":"Keizman D et al (2009) Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 285(1\u20132):95\u201399","journal-title":"J Neurol Sci"},{"issue":"1","key":"2923_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bone.2012.10.025","volume":"52","author":"J Makovey","year":"2013","unstructured":"Makovey J et al (2013) Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone 52(1):400\u2013406","journal-title":"Bone"},{"issue":"1","key":"2923_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00774-018-0905-4","volume":"37","author":"J Hwang","year":"2019","unstructured":"Hwang J et al (2019) Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study. J Bone Min Metab 37(1):142\u2013151","journal-title":"J Bone Min Metab"},{"key":"2923_CR32","doi-asserted-by":"publisher","first-page":"580167","DOI":"10.3389\/fphys.2020.580167","volume":"11","author":"JR Moffett","year":"2020","unstructured":"Moffett JR et al (2020) Acetate revisited: a key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis-Part 1: Acetyl-CoA, acetogenesis and Acyl-CoA short-chain synthetases. Front Physiol 11:580167","journal-title":"Front Physiol"},{"issue":"12","key":"2923_CR33","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00198-021-06037-8","volume":"32","author":"N Panahi","year":"2021","unstructured":"Panahi N et al (2021) Metabolomic biomarkers of low BMD: a systematic review. Osteoporos Int 32(12):2407\u20132431","journal-title":"Osteoporos Int"},{"issue":"4","key":"2923_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jbmr.4240","volume":"36","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) Metabolomics Insights into osteoporosis through Association with Bone Mineral density. J Bone Min Res 36(4):729\u2013738","journal-title":"J Bone Min Res"},{"issue":"18","key":"2923_CR35","first-page":"9591","volume":"24","author":"WD Liang","year":"2020","unstructured":"Liang WD et al (2020) Metabolomics and its application in the mechanism analysis on diabetic bone metabolic abnormality. Eur Rev Med Pharmacol Sci 24(18):9591\u20139600","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"2923_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0014-827X(01)01126-0","volume":"56","author":"MT Conconi","year":"2001","unstructured":"Conconi MT et al (2001) Essential amino acids increase the growth and alkaline phosphatase activity in osteoblasts cultured in vitro. Farmaco 56(10):755\u2013761","journal-title":"Farmaco"},{"issue":"5","key":"2923_CR37","first-page":"1027","volume":"25","author":"BH Goodpaster","year":"2017","unstructured":"Goodpaster BH, Sparks LM (2017) Metabolic Flex Health Disease Cell Metab 25(5):1027\u20131036","journal-title":"Metabolic Flex Health Disease Cell Metab"},{"key":"2923_CR38","doi-asserted-by":"crossref","unstructured":"Podg\u00f3rska B et al (2022) Applications of Metabolomics in Calcium Metabolism disorders in humans. Int J Mol Sci, 23(18)","DOI":"10.3390\/ijms231810407"},{"key":"2923_CR39","doi-asserted-by":"publisher","first-page":"993253","DOI":"10.3389\/fendo.2022.993253","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao Z et al (2022) Application of metabolomics in osteoporosis research. Front Endocrinol (Lausanne) 13:993253","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2923_CR40","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mas.21562","volume":"37","author":"L Cui","year":"2018","unstructured":"Cui L, Lu H, Lee YH (2018) Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases. Mass Spectrom Rev 37(6):772\u2013792","journal-title":"Mass Spectrom Rev"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02923-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-024-02923-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02923-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:43:10Z","timestamp":1737459790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-024-02923-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2923"],"URL":"https:\/\/doi.org\/10.1007\/s40520-024-02923-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5212282\/v1","asserted-by":"object"}]},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"was obtained from all subjects involved in the study.Written informed consent has been obtained from the patient(s) to publish this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of The Third Hospital of Mian Yang (2024,Reviewed, No.3 and February 26, 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}